Conference abstract · 15 Jun 2017
Conference abstractPublished 17 Oct 2016
Mechanistic role of BR-DIM in human prostate cancer: Clinical experience
Wayne State University School of Medicine,USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Prostate cancer (PCa) is treated with androgen deprivation therapy (ADT) but it becomes refractory and leads to metastasis (mCRPC) which is incurable, suggesting that innovative treatment options are urgently needed. We found deregulated expression of microRNAs (miRNAs) such as miR-34a, miR-124, miR-27b, miR-320 and the let-7 family, and it appears to play important roles in regulating androgen receptor (AR) splice variant expression. The miR-320 and let-7 family inhibit the expression of stem cell markers such as Lin28B, EZH2, Nanog, Oct4 and CD44, which are associated with enzalutamide resistance, and thus could be responsible for the development of mCRPC. These dysregulations can be attenuated by treatment of PCa cells with 3,3âÂ?Â?-Diindolylmethane (BR-DIM), which led to conduct a clinical trial. In the phase II clinical trial with localized PCa pateints were treated with BR-DIM at a dose of 225 mg orally twice daily for a minimum of 14 days. DIM levels and AR activity were measured at the time of prostatectomy. Moreover, we also assessed the level of expression of miRNAs and the expression of AR and its splice variants in the radical prostatectomy specimens and compared it with diagnostic biopsy specimens. We found that BR-DIM treatment caused down regulation in the expression of AR, AR splice variants, Lin28B and EZH2, which appears to be mediated through the re-expression of let-7, miR-27b and miR-320 and miR-34a in human PCa specimens after BR-DIM treatment. In summary, our results provides the scientific basis for a âÂ?Â?proof-of-conceptâÂ? for therapeutic clinical trial for achieving better treatment outcome which will have a significant impact on the management of PCa patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Transrectal prostate cancer ablation by robotic High-intensity focused ultrasound (HIFU) at 3 MHz: 20 years clinical experience
Conference abstract · 18 Sep 2017
The role of the human polyomavirus BK in the development of prostate cancer
Conference abstract · 22 Aug 2016
Histoscanning™ for detection of prostate cancer: Does it have any role in routine clinical practice?
Conference abstract · 28 Sep 2015
Synthesis and preliminary mechanistic evaluation of N-(Substituted-1,3-Benzothiazol-2-yl)-2-(4- Substituted-Piperazin-1-yl) Acetamide derivatives with potent antiproliferative activity on human cancer cell lines
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Fazlul H Sarkar”

